{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:34:13Z","timestamp":1790426053810,"version":"4.1.0"},"reference-count":43,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,1]]},"abstract":"<jats:p>The islet in type 2 diabetes is characterized by a deficit in \u03b2-cell mass, increased \u03b2-cell apoptosis, and impaired insulin secretion. Also, islets in type 2 diabetes often contain deposits of islet amyloid derived from islet amyloid polypeptide (IAPP), a 37\u2013amino acid protein cosecreted with insulin by \u03b2-cells. Several lines of evidence suggest that proteins with a capacity to develop amyloid fibrils may also form small toxic oligomers that can initiate apoptosis. The amino acid sequence of IAPP in rats and mice is identical and differs from that in humans by substitution of proline residues in the amyloidogenic sequence so that the protein no longer forms amyloid fibrils or is cytotoxic. In the present study, we report a novel rat model for type 2 diabetes: rats transgenic for human IAPP (the HIP rat). HIP rats develop diabetes between 5 and 10 months of age, characterized by an \u223c60% deficit in \u03b2-cell mass that is due to an increased frequency of \u03b2-cell apoptosis. HIP rats develop islet amyloid, but the extent of amyloid was not related to the frequency of \u03b2-cell apoptosis (r = 0.10, P = 0.65), whereas the fasting blood glucose was (r = 0.77, P &amp;lt; 0.001). The frequency of \u03b2-cell apoptosis was related to the frequency of \u03b2-cell replication (r = 0.97, P &amp;lt; 0.001) in support of the hypothesis that replicating cells are more vulnerable to apoptosis than nondividing cells. The HIP rat provides additional evidence in support of the potential role of IAPP oligomer formation toward the increased frequency of apoptosis in type 2 diabetes, a process that appears to be compounded by glucose toxicity when hyperglycemia supervenes.<\/jats:p>","DOI":"10.2337\/diabetes.53.6.1509","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"1509-1516","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":232,"title":["Diabetes Due to a Progressive Defect in \u03b2-Cell Mass in Rats Transgenic for Human Islet Amyloid Polypeptide (HIP Rat)"],"prefix":"10.2337","volume":"53","author":[{"given":"Alexandra E.","family":"Butler","sequence":"first","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jang","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Gurlo","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maynard D.","family":"Carty","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Soeller","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031206384672300_R1","doi-asserted-by":"crossref","unstructured":"Cavaghan MK, Ehrmann DA, Polonsky KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest\u2008106:329\u2013333,2000","DOI":"10.1172\/JCI10761"},{"key":"2022031206384672300_R2","doi-asserted-by":"crossref","unstructured":"LeRoith D: Beta-cell dysfunction and insulin resistance in type-2 diabetes: role of metabolic and genetic abnormalities. Am J Med\u2008113 S6A:3S\u201311S,2002","DOI":"10.1016\/S0002-9343(02)01276-7"},{"key":"2022031206384672300_R3","doi-asserted-by":"crossref","unstructured":"Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res\u20084:110\u2013125,1985","DOI":"10.1159\/000156969"},{"key":"2022031206384672300_R4","doi-asserted-by":"crossref","unstructured":"Butler AE, Juliette J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes\u200852:102\u2013110,2003","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2022031206384672300_R5","doi-asserted-by":"crossref","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature\u2008368:756\u2013760,1994","DOI":"10.1038\/368756a0"},{"key":"2022031206384672300_R6","doi-asserted-by":"crossref","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes\u200848:491\u2013498,1999","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2022031206384672300_R7","doi-asserted-by":"crossref","unstructured":"Ritzel RA, Butler PC: Replication increases \u03b2-cell vulnerability to human islet amyloid polypeptide\u2013induced apoptosis. Diabetes\u200852:1701\u20131708,2003","DOI":"10.2337\/diabetes.52.7.1701"},{"key":"2022031206384672300_R8","doi-asserted-by":"crossref","unstructured":"Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes\u200839:752\u2013756,1990","DOI":"10.2337\/diabetes.39.6.752"},{"key":"2022031206384672300_R9","unstructured":"Butler PC: Islet amyloid and its potential role in the pathogenesis of type II diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott, William, and Wilkins,1996, p.113\u2013117"},{"key":"2022031206384672300_R10","doi-asserted-by":"crossref","unstructured":"Ohsawa H, Kanatsuka A, Yamaguchi T: Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun\u2008160:961\u2013967,1989","DOI":"10.1016\/0006-291X(89)92529-1"},{"key":"2022031206384672300_R11","doi-asserted-by":"crossref","unstructured":"Maloy AL, Longnecker DS, Greenberg ER: The relation of islet amyloid to the clinical type of diabetes. Hum Pathol\u200812:917\u2013922,1981","DOI":"10.1016\/S0046-8177(81)80197-9"},{"key":"2022031206384672300_R12","doi-asserted-by":"crossref","unstructured":"Narita R, Toshimori H, Nakazato M, Kuribayashi T, Toshimori T, Kawabata K, Takahashi K, Masukura S: Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients. Diabetes Res Clin Pract\u200815:3\u201314,1992","DOI":"10.1016\/0168-8227(92)90060-5"},{"key":"2022031206384672300_R13","doi-asserted-by":"crossref","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of athogenesis. Science\u2008300:486\u2013489,2003","DOI":"10.1126\/science.1079469"},{"key":"2022031206384672300_R14","doi-asserted-by":"crossref","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr: Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature\u2008418:291,2002","DOI":"10.1038\/418291a"},{"key":"2022031206384672300_R15","doi-asserted-by":"crossref","unstructured":"Betsholtz C, Christmanson L, Engstrom U, Rorsman F, Jordan K, O\u2019Brien TD, Murtaugh M, Johnson KH, Westermark P: Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes\u200839:118\u2013122,1990","DOI":"10.2337\/diabetes.39.1.118"},{"key":"2022031206384672300_R16","doi-asserted-by":"crossref","unstructured":"Jordan K, Murtaugh MP, O\u2019Brien TD, Westermark P, Betsholtz C, Johnson KH: Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes. Biochem Biophys Res Commun\u2008169:502\u2013507,1990","DOI":"10.1016\/0006-291X(90)90359-U"},{"key":"2022031206384672300_R17","doi-asserted-by":"crossref","unstructured":"Ohagi S, Nishi M, Bell GI, Ensinck JW, Steiner DF: Sequences of islet amyloid polypeptide precursors of an old world monkey, the pig-tailed macaque (Macaca nemestrini), and the dog (Canis familiaris). Diabetelogia\u200834:555\u2013558,1991","DOI":"10.1007\/BF00400272"},{"key":"2022031206384672300_R18","doi-asserted-by":"crossref","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A\u200887:5036\u20135040,1990","DOI":"10.1073\/pnas.87.13.5036"},{"key":"2022031206384672300_R19","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TD, Butler PC, Westermark P, Johnson KH: Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of NIDDM. Vet Pathol\u200830:317\u2013332,1993","DOI":"10.1177\/030098589303000401"},{"key":"2022031206384672300_R20","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Ntnl Acad Sci U S A\u200893:7283\u20137288,1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031206384672300_R21","doi-asserted-by":"crossref","unstructured":"Couce M, Kane LA, O\u2019Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Diabetes\u200845:1094\u20131101,1996","DOI":"10.2337\/diabetes.45.8.1094"},{"key":"2022031206384672300_R22","doi-asserted-by":"crossref","unstructured":"Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia\u200842:427\u2013434,1999","DOI":"10.1007\/s001250051175"},{"key":"2022031206384672300_R23","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Soeller WC, Butler PC: Increased \u03b2-cell apoptosis prevents adaptive increase in \u03b2-cell mass in mouse model of type-2 diabetes. Diabetes\u200852:2304\u20132314,2003","DOI":"10.2337\/diabetes.52.9.2304"},{"key":"2022031206384672300_R24","doi-asserted-by":"crossref","unstructured":"Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter K, Butler PC: Islet amyloid-associated diabetes in obese Avy\/a mice expressing human islet amyloid polypeptide. Diabetes\u200847:743\u2013750,1998","DOI":"10.2337\/diabetes.47.5.743"},{"key":"2022031206384672300_R25","doi-asserted-by":"crossref","unstructured":"Bonner-Weir S: Islet growth and development in the adult. J Mol Endocrinol\u200824:297\u2013302,2000","DOI":"10.1677\/jme.0.0240297"},{"key":"2022031206384672300_R26","doi-asserted-by":"crossref","unstructured":"Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of \u03b2-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes\u200844:249\u2013256,1995","DOI":"10.2337\/diabetes.44.3.249"},{"key":"2022031206384672300_R27","doi-asserted-by":"crossref","unstructured":"Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY: Glucose induced beta cell production of IL-1 beta contributes to glucose toxicity in human pancreatic islets. J Clin Invest\u2008110:851\u2013860,2002","DOI":"10.1172\/JCI200215318"},{"key":"2022031206384672300_R28","doi-asserted-by":"crossref","unstructured":"Efanova BE, Zaitsev SV, Zhivotovsky B, Kohler M, Efendic S, Orrenius S, Berggren P-O: Glucose and tolbutamide induce apoptosis in pancreatic beta cells. J Biol Chem\u2008273:33501\u201333507,1998","DOI":"10.1074\/jbc.273.50.33501"},{"key":"2022031206384672300_R29","doi-asserted-by":"crossref","unstructured":"Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI: Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes\u200844:1447\u20131457,1995","DOI":"10.2337\/diabetes.44.12.1447"},{"key":"2022031206384672300_R30","doi-asserted-by":"crossref","unstructured":"Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS: Role of apoptosis in failure of \u03b2-cell mass compensation for insulin resistance and \u03b2-cell defects in the male Zucker diabetic fatty rat. Diabetes\u200847:358\u2013364,1998","DOI":"10.2337\/diabetes.47.3.358"},{"key":"2022031206384672300_R31","doi-asserted-by":"crossref","unstructured":"Finegood DT, McArthur MD, Kojwangt D, Thomas MJ, Topp BG, Leonard T, Buckingham RE: \u03b2-Cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death. Diabetes\u200850:1021\u20131029,2001","DOI":"10.2337\/diabetes.50.5.1021"},{"key":"2022031206384672300_R32","doi-asserted-by":"crossref","unstructured":"Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Tamura N, Hosada K, Nakao K: Molecular cloning of rat leptin receptor isoform complementary DNAs: identification of missense mutation in Zucker fatty (fa\/fa) rats. Biochem Biophys Res Commun\u2008225:75\u201383,1996","DOI":"10.1006\/bbrc.1996.1133"},{"key":"2022031206384672300_R33","doi-asserted-by":"crossref","unstructured":"Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet\u200813:18\u201319,1996","DOI":"10.1038\/ng0596-18"},{"key":"2022031206384672300_R34","doi-asserted-by":"crossref","unstructured":"Shimabukuro M, Zhou Y-T, Levi M, Unger RH: Fatty acid-induced \u03b2-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A\u200895:2498\u20132502,1998","DOI":"10.1073\/pnas.95.5.2498"},{"key":"2022031206384672300_R35","doi-asserted-by":"crossref","unstructured":"Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH: Beta-cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A\u200891:10878\u201310882,1994","DOI":"10.1073\/pnas.91.23.10878"},{"key":"2022031206384672300_R36","doi-asserted-by":"crossref","unstructured":"Lee Y, Hirose H, Zhou Y-T, Esser V, McGarry JD, Unger RH: Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes\u200846:408\u2013413,1997","DOI":"10.2337\/diabetes.46.3.408"},{"key":"2022031206384672300_R37","unstructured":"Adler JH, Kalman R, Lazarovici G, Bar-On H, Ziv E: Achieving predictable model of type 2 diabetes in the sand rat. In Frontiers in Diabetic Research: Lessons from Animal Diabetes III. Shafrir E, Ed. London, Smith-Gordon,1991, p.212\u2013214"},{"key":"2022031206384672300_R38","doi-asserted-by":"crossref","unstructured":"Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced \u03b2-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes\u200848:738\u2013744,1999","DOI":"10.2337\/diabetes.48.4.738"},{"key":"2022031206384672300_R39","unstructured":"Goto Y, Suzuki KI, Sasaki M, Ono T, Abe S: GK rat as a model of non-obese, non-insulin dependent diabetes: selective breeding over 35 generations. In Lessons from Animal Studies II. Shafrir E, Reynold AE, Eds. London, Libbey,1998, p.301\u2013303"},{"key":"2022031206384672300_R40","doi-asserted-by":"crossref","unstructured":"Movassat J, Saulnier C, Serradas P, Portha B: Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia\u200840:916\u2013925,1997","DOI":"10.1007\/s001250050768"},{"key":"2022031206384672300_R41","doi-asserted-by":"crossref","unstructured":"Serradas P, Gangnerau MN, Giroix MH, Saulnier C, Potha B: Impaired pancreatic beta cell function in the fetal GK rat: impact of diabetic inheritance. J Clin Invest\u2008101:899\u2013904,1998","DOI":"10.1172\/JCI368"},{"key":"2022031206384672300_R42","doi-asserted-by":"crossref","unstructured":"Plachot C, Movassat J, Portha B: Impaired beta cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes. Histochem Cell Biol\u2008116:131\u2013139,2001","DOI":"10.1007\/s004180100302"},{"key":"2022031206384672300_R43","doi-asserted-by":"crossref","unstructured":"Serradas P, Goya L, Lacorne M, Gangnerua M-N, Ramos S, Alvarez C, Pascual-Leone A-M, Portha B: Fetal insulin-like growth factor-2 production is impaired in the GK rat model of type 2 diabetes. Diabetes\u200851:392\u2013397,2002","DOI":"10.2337\/diabetes.51.2.392"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/6\/1509\/376650\/zdb00604001509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/6\/1509\/376650\/zdb00604001509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:22:23Z","timestamp":1667406143000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/6\/1509\/11764\/Diabetes-Due-to-a-Progressive-Defect-in-Cell-Mass"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,1]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.6.1509","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,1]]}}}